D. Andrew Tompkins

2.7k total citations
49 papers, 1.9k citations indexed

About

D. Andrew Tompkins is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Anesthesiology and Pain Medicine. According to data from OpenAlex, D. Andrew Tompkins has authored 49 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Public Health, Environmental and Occupational Health, 13 papers in Epidemiology and 12 papers in Anesthesiology and Pain Medicine. Recurrent topics in D. Andrew Tompkins's work include Opioid Use Disorder Treatment (23 papers), Pain Management and Opioid Use (12 papers) and Substance Abuse Treatment and Outcomes (11 papers). D. Andrew Tompkins is often cited by papers focused on Opioid Use Disorder Treatment (23 papers), Pain Management and Opioid Use (12 papers) and Substance Abuse Treatment and Outcomes (11 papers). D. Andrew Tompkins collaborates with scholars based in United States, Canada and Australia. D. Andrew Tompkins's co-authors include Eric C. Strain, Kelly E. Dunn, George E. Bigelow, Andrew S. Huhn, Claudia M. Campbell, Peggy Compton, Patrick H. Finan, Michael T. Smith, Amer M. Zeidan and Caiyun Liao and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and American Journal of Psychiatry.

In The Last Decade

D. Andrew Tompkins

47 papers receiving 1.8k citations

Peers

D. Andrew Tompkins
Carlos Roncero Spain
Leslie Amass United States
Keith G. Heinzerling United States
Rachel Vickers‐Smith United States
Masatoshi Inagaki Japan
Ingemar Thiblin Sweden
Ramy Mahmoud United States
Christopher L. Hunter United States
Anne Berghöfer Germany
Surendra K. Mattoo India
Carlos Roncero Spain
D. Andrew Tompkins
Citations per year, relative to D. Andrew Tompkins D. Andrew Tompkins (= 1×) peers Carlos Roncero

Countries citing papers authored by D. Andrew Tompkins

Since Specialization
Citations

This map shows the geographic impact of D. Andrew Tompkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Andrew Tompkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Andrew Tompkins more than expected).

Fields of papers citing papers by D. Andrew Tompkins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Andrew Tompkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Andrew Tompkins. The network helps show where D. Andrew Tompkins may publish in the future.

Co-authorship network of co-authors of D. Andrew Tompkins

This figure shows the co-authorship network connecting the top 25 collaborators of D. Andrew Tompkins. A scholar is included among the top collaborators of D. Andrew Tompkins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Andrew Tompkins. D. Andrew Tompkins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McCuistian, Caravella, et al.. (2024). Induction to Methadone 80 mg in the First Week of Treatment of Patients Who Use Fentanyl: A Case Series From an Outpatient Opioid Treatment Program. Journal of Addiction Medicine. 18(5). 580–585. 3 indexed citations
2.
Meacham, Meredith C., Alicia L. Nobles, D. Andrew Tompkins, & Johannes Thrul. (2022). “I got a bunch of weed to help me through the withdrawals”: Naturalistic cannabis use reported in online opioid and opioid recovery community discussion forums. PLoS ONE. 17(2). e0263583–e0263583. 19 indexed citations
3.
Huhn, Andrew S., Eric C. Strain, George E. Bigelow, et al.. (2021). Methadone maintenance patients lack analgesic response to a cumulative intravenous dose of 32 mg of hydromorphone. Drug and Alcohol Dependence. 226. 108869–108869. 6 indexed citations
4.
Smith, Michael T., Chung Jung Mun, Bethany Remeniuk, et al.. (2020). Experimental sleep disruption attenuates morphine analgesia: findings from a randomized trial and implications for the opioid abuse epidemic. Scientific Reports. 10(1). 20121–20121. 20 indexed citations
5.
Jarvis, Brantley P., August F. Holtyn, Shrinidhi Subramaniam, et al.. (2018). Extended‐release injectable naltrexone for opioid use disorder: a systematic review. Addiction. 113(7). 1188–1209. 149 indexed citations
6.
Bisaga, Adam, Paolo Mannelli, Miao Yu, et al.. (2018). Outpatient transition to extended-release injectable naltrexone for patients with opioid use disorder: A phase 3 randomized trial. Drug and Alcohol Dependence. 187. 171–178. 34 indexed citations
7.
Huhn, Andrew S., Mary M. Sweeney, Robert K. Brooner, et al.. (2018). Prefrontal cortex response to drug cues, craving, and current depressive symptoms are associated with treatment outcomes in methadone-maintained patients. Neuropsychopharmacology. 44(4). 826–833. 33 indexed citations
8.
Satre, Derek D., Brian Borsari, D. Andrew Tompkins, & Danielle E. Ramo. (2018). Psychiatric Disorders and Comorbid Cannabis Use. The Journal of Clinical Psychiatry. 79(6). 2 indexed citations
9.
Huhn, Andrew S., Eric C. Strain, D. Andrew Tompkins, & Kelly E. Dunn. (2018). A hidden aspect of the U.S. opioid crisis: Rise in first-time treatment admissions for older adults with opioid use disorder. Drug and Alcohol Dependence. 193. 142–147. 82 indexed citations
10.
Tompkins, D. Andrew, et al.. (2017). Providing chronic pain management in the “Fifth Vital Sign” Era: Historical and treatment perspectives on a modern-day medical dilemma. Drug and Alcohol Dependence. 173. S11–S21. 175 indexed citations
11.
Drescher, Jack, Alan Schwartz, Chris McIntosh, et al.. (2016). The Growing Regulation of Conversion Therapy. Journal of Medical Regulation. 102(2). 7–12. 51 indexed citations
12.
Dunn, Kelly E., Patrick H. Finan, D. Andrew Tompkins, Michael Fingerhood, & Eric C. Strain. (2015). Characterizing pain and associated coping strategies in methadone and buprenorphine-maintained patients. Drug and Alcohol Dependence. 157. 143–149. 42 indexed citations
13.
Liao, Caiyun, Dongyu Zhang, Chemtai Mungo, D. Andrew Tompkins, & Amer M. Zeidan. (2014). Is diabetes mellitus associated with increased incidence and disease-specific mortality in endometrial cancer? A systematic review and meta-analysis of cohort studies. Gynecologic Oncology. 135(1). 163–171. 105 indexed citations
14.
Tompkins, D. Andrew, et al.. (2014). Recruitment Techniques for Alcohol Pharmacotherapy Clinical Trials. Addictive Disorders & Their Treatment. 14(4). 211–219. 3 indexed citations
15.
Tompkins, D. Andrew, Michael T. Smith, Miriam Z. Mintzer, Claudia M. Campbell, & Eric C. Strain. (2013). A Double Blind, within Subject Comparison of Spontaneous Opioid Withdrawal from Buprenorphine versus Morphine. Journal of Pharmacology and Experimental Therapeutics. 348(2). 217–226. 29 indexed citations
16.
Byne, William, Susan J. Bradley, Eli Coleman, et al.. (2012). Treatment of Gender Identity Disorder. American Journal of Psychiatry. 169(8). 875–876. 10 indexed citations
17.
Fertig, Joanne B., Megan L. Ryan, Daniel E. Falk, et al.. (2012). A Double‐Blind, Placebo‐Controlled Trial Assessing the Efficacy of Levetiracetam Extended‐Release in Very Heavy Drinking Alcohol‐Dependent Patients. Alcoholism Clinical and Experimental Research. 36(8). 1421–1430. 43 indexed citations
18.
Tompkins, D. Andrew & Claudia M. Campbell. (2011). Opioid-Induced Hyperalgesia: Clinically Relevant or Extraneous Research Phenomenon?. Current Pain and Headache Reports. 15(2). 129–136. 88 indexed citations
19.
20.
Gerbino-Rosen, Ginny, David Roofeh, D. Andrew Tompkins, et al.. (2005). Hematological Adverse Events in Clozapine-Treated Children and Adolescents. Journal of the American Academy of Child & Adolescent Psychiatry. 44(10). 1024–1031. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carlos Roncero Breakdown of academic impact, for papers by Leslie Amass Breakdown of academic impact, for papers by Keith G. Heinzerling Breakdown of academic impact, for papers by Rachel Vickers‐Smith Breakdown of academic impact, for papers by Masatoshi Inagaki Breakdown of academic impact, for papers by Ingemar Thiblin Breakdown of academic impact, for papers by Ramy Mahmoud Breakdown of academic impact, for papers by Christopher L. Hunter Breakdown of academic impact, for papers by Anne Berghöfer Breakdown of academic impact, for papers by Surendra K. Mattoo
Rankless by CCL
2026